Ken A. Brameld

Ken A. Brameld

Consultant / Adviseur bij Samsara Biocapital LLC

51 jaar
Health Technology
Consumer Services
Finance

Oorsprong van het eerstegraads netwerk van Ken A. Brameld

EntiteitType entiteitIndustrie
29
Private Company Investment Managers 29

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Ken A. Brameld via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Perry Karsen

Dolca Thomas

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Srini Akkaraju Akkaraju

Perry Karsen

Dan Spiegelman

Robert Baffi

Betsy Santos

Corporate Officer/Principal

Corporate Officer/Principal

Treasurer

Director/Board Member

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Robert Stein

David Parry

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Keith Gottesdiener

Corporate Officer/Principal

Miscellaneous Commercial Services

Abrar Hussain

Corporate Officer/Principal

BIOMARIN PHARMACEUTICAL INC. Biotechnology

Dan Spiegelman

Robert Baffi

Director of Finance/CFO

Corporate Officer/Principal

Miscellaneous Commercial Services

Srini Akkaraju Akkaraju

Stephen Shuttleworth

Founder

Corporate Officer/Principal

INTERCEPT PHARMACEUTICALS, INC. Pharmaceuticals: Major

Srini Akkaraju Akkaraju

Keith Gottesdiener

Director/Board Member

Director/Board Member

PRINCIPIA BIOPHARMA INC. Pharmaceuticals: Major

Srini Akkaraju Akkaraju

Michael Dybbs

Betsy Santos

Dolca Thomas

Director/Board Member

Director/Board Member

Human Resources Officer

Chief Tech/Sci/R&D Officer

Investment Banks/Brokers

Cory Freedland

Analyst-Equity

Investment Managers

Srini Akkaraju Akkaraju

Cory Freedland

Private Equity Investor

Private Equity Investor

College/University

Perry Karsen

Robert Stein

Graduate Degree

Doctorate Degree

Stanford University College/University

Srini Akkaraju Akkaraju

Dan Spiegelman

Abraham Bassan

Roger Zhang

Doctorate Degree

Undergraduate Degree

Graduate Degree

Graduate Degree

University of Pennsylvania College/University

Keith Gottesdiener

Ravichandran Rao

Doctorate Degree

Doctorate Degree

Wake Forest University College/University

Cory Freedland

Doctorate Degree

Connecticut College College/University

Cory Freedland

Undergraduate Degree

College/University

Abrar Hussain

Dolca Thomas

Undergraduate Degree

Doctorate Degree

Investment Managers

Srini Akkaraju Akkaraju

Michael Dybbs

Private Equity Investor

Private Equity Investor

Investment Managers

Abrar Hussain

Founder

Kellogg School of Management College/University

Perry Karsen

Cory Freedland

Masters Business Admin

Masters Business Admin

Stanford Graduate School of Business College/University

Dan Spiegelman

Aditya Asokan

Masters Business Admin

Graduate Degree

Harvard College College/University

Michael Dybbs

Keith Gottesdiener

Undergraduate Degree

Undergraduate Degree

Biotechnology

Chris Richard

Cory Freedland

Director/Board Member

Director/Board Member

Vanderbilt Law School College/University

Abrar Hussain

Graduate Degree

Columbia University College of Physicians & Surgeons College/University

Keith Gottesdiener

Corporate Officer/Principal

Financial Conglomerates

Keith Gottesdiener

Chief Executive Officer

Investment Managers

Srini Akkaraju Akkaraju

Michael Dybbs

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Keith Gottesdiener

Director/Board Member

Biotechnology

Cory Freedland

Director/Board Member

Biotechnology

Robert Baffi

Cory Freedland

Director/Board Member

Director/Board Member

Biotechnology

Srini Akkaraju Akkaraju

Robert Stein

Director/Board Member

Chief Tech/Sci/R&D Officer

Investment Managers

Srini Akkaraju Akkaraju

Michael Dybbs

Director/Board Member

Director/Board Member

PRIME MEDICINE, INC. Biotechnology

Keith Gottesdiener

Chief Executive Officer

Biotechnology

Srini Akkaraju Akkaraju

Cory Freedland

Director/Board Member

Director/Board Member

CHINOOK THERAPEUTICS, INC. Pharmaceuticals: Major

Srini Akkaraju Akkaraju

Dolca Thomas

Director/Board Member

Director/Board Member

Medical/Nursing Services

Srini Akkaraju Akkaraju

Perry Karsen

Robert Stein

Richard D. van Doren

Stephen Shuttleworth

Director/Board Member

Chairman

Consultant / Advisor

Director of Finance/CFO

Consultant / Advisor

JIYA ACQUISITION CORP. Financial Conglomerates

Srini Akkaraju Akkaraju

Perry Karsen

Dan Spiegelman

Richard D. van Doren

Cory Freedland

Chairman

Director/Board Member

Director/Board Member

Director of Finance/CFO

Chief Investment Officer

CARGO THERAPEUTICS, INC. Biotechnology

Srini Akkaraju Akkaraju

Abraham Bassan

Roger Zhang

Director/Board Member

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Richard D. van Doren

Stephen Shuttleworth

Cory Freedland

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

Director/Board Member

Tentarix Biotherapeutics, Inc.

Srini Akkaraju Akkaraju

Cory Freedland

Director/Board Member

Director/Board Member

MINERALYS THERAPEUTICS, INC. Biotechnology

Srini Akkaraju Akkaraju

Roger Zhang

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Srini Akkaraju Akkaraju

Cory Freedland

Director/Board Member

Director/Board Member

Theia Therapeutics, Inc.

Srini Akkaraju Akkaraju

Richard D. van Doren

Director/Board Member

Director of Finance/CFO

Investment Managers

Perry Karsen

Abraham Bassan

Private Equity Investor

Corporate Officer/Principal

Investment Banks/Brokers

Cory Freedland

Corporate Officer/Principal

Statistieken

Internationaal

Verenigde Staten 48
Verenigd Koninkrijk 3

Sectoraal

Health Technology 22
Finance 12
Consumer Services 12
Commercial Services 4
Health Services 2

Operationeel

Director/Board Member 155
Corporate Officer/Principal 71
Independent Dir/Board Member 47
Private Equity Investor 36
Undergraduate Degree 24
  1. Beurs
  2. Insiders
  3. Ken A. Brameld
  4. Bedrijfsconnecties
-40 % Uitzonderlijk verlengd: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU